# Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)

> **NCT01544582** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 713 (actual)

## Conditions studied

- Hepatitis C Chronic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01544582
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 713 (ACTUAL)
- **Last updated:** 2016-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01544582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01544582, "Drug Utilization of Boceprevir and Clinical Management of Health Outcomes of Interest in Chronic Hepatitis C Participants (P08518)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01544582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*